Search results
Diana Blankman
US News & World Report· 5 days agoDiana has spent more than 25 years in the healthcare and non-profit sectors, leading the development and execution of strategic corporate social responsibility programs, community ...
NorthShore Health Centers to open facility in Crown Point
The Times of Northwest Indiana· 1 day agoContent by NorthShore Health. Crown Point residents will have greater access to comprehensive ...
Earnings call: Weave reports robust Q1 growth, raises full-year outlook
Investing.com· 6 days agoWeave (Ticker: WEAV), a customer communication platform, has reported a significant increase in its...
Abortion providers stretched thin as demand skyrockets following Roe v. Wade reversal
WTVD-TV 11 Raleigh-Durham· 2 days agoWhen Florida enacted its six-week abortion ban last week, clinics in several other Southern and...
Mohave County supervisor candidates share thoughts, strategies
Mohave Daily News· 1 day agoSix candidates for seats on the Mohave County Board of Supervisors on Thursday shared their plans to...
Innosphere starts paediatric clinical trial for Novostim ADHD device
Clinical Trials Arena via Yahoo Finance· 4 days agoThe Novostim treatment will be administered over 20 minutes, where patient attention will be...
Newsweek selects eHealth Technologies as one of World’s Best Digital Health Companies | Healthcare...
Healthcare Dive· 4 days agoPittsburgh, PA, MAY 3, 2024 – eHealth Technologies, a leading healthcare technology company that advances the delivery of life-altering care, has been named by Newsweek as ...
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam...
French entrepreneur Thierry Carbou unleashes AI potential across industries with DotChat
Digital Journal· 1 day agoIn a significant leap for artificial intelligence applications in business, French entrepreneur...
Madrigal Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Re
Guru Focus· 6 hours agoOn May 7, 2024, Madrigal Pharmaceuticals Inc (MDGL, Financial) disclosed its first-quarter financial outcomes for the year, emphasizing the launch of its newly FDA-approved NASH treatment, Rezdiffra ...